{{Rsnum
|rsid=2901331
|Gene=CNTNAP5
|Chromosome=2
|position=124570373
|Orientation=plus
|GMAF=0.2691
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CNTNAP5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 43.4 | 46.0
| HCB | 0.0 | 19.0 | 81.0
| JPT | 1.8 | 21.4 | 76.8
| YRI | 9.5 | 48.3 | 42.2
| ASW | 10.5 | 47.4 | 42.1
| CHB | 0.0 | 19.0 | 81.0
| CHD | 1.8 | 22.0 | 76.1
| GIH | 13.9 | 46.5 | 39.6
| LWK | 14.5 | 45.5 | 40.0
| MEX | 5.2 | 27.6 | 67.2
| MKK | 9.0 | 44.2 | 46.8
| TSI | 7.8 | 38.2 | 53.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20339536
|Trait=Response to statin therapy
|Title=Genome-wide association of lipid-lowering response to statins in combined study populations
|RiskAllele=A
|Pval=0.000006
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}